Facts and Figures
| Table 01 | OPERATING DATA |
| $ in millions | 2008 | 2007 | Change in % |
|---|---|---|---|
| Selected key figures | |||
| Net revenue | 10,612 |
9,720 |
9 % |
| Earnings before interest and taxes, depreciation and amortization (EBITDA) | 2,088 |
1,943 |
7 % |
| Earnings before interest and taxes (EBIT) | 1,672 |
1,580 |
6 % |
| Net income | 818 |
717 |
14 % |
| Net cash flow from operating activities | 1,016 |
1,200 |
(15 %) |
| Free Cash Flow 1 | 343 |
657 |
(48 %) |
| Capital expenditure (net) | 673 |
543 |
24 % |
| Acquisitions, investments and purchases of intangible assets (net) | 218 |
234 |
(7 %) |
| Earnings per ordinary share in US - $ | 2.75 |
2.43 |
13 % |
| Dividend per ordinary share 2 in € | 0.58 |
0.54 |
7 % |
| EBIT margin in % | 15.8 |
16.3 |
– |
| Return in invested capital (ROIC) in % | 8.6 |
8.4 |
– |
| Equity to assets in % | 40.0 |
39.3 |
– |
| 1 Before acquisitions and dividends 2 2008: Proposal for approval at the Annual General Meeting on May 7, 2009. |
|||
| Chart 01 | Revenue by region |
| Chart 02 | Revenue by segment |
| Chart 03 | Fresenius medical care´s patients worldwide |
| Table 02 | FRESENIUS MEDICAL CARE'S CLINICS WORLDWIDE |
| Number | 2008 | 2007 | Change |
|---|---|---|---|
| North America | 1,686 |
1,602 |
5 % |
| Europe / Middle East /Africa | 400 |
362 |
10 % |
| Latin America | 177 |
169 |
5 % |
| Asia-Pacific | 125 |
105 |
19 % |
| TOTAL | 2,388 |
2,238 |
7 % |
| Chart 04 | Dialysis services worldwide |
| Table 03 | MARKET POSITION IN MAJOR PRODUCT GROUPS |
| Rank 1 | Rank 2 | Rank 3 | |
|---|---|---|---|
Dialyzers |
Fresenius Medical Care |
Gambro |
Asahi |
Dialysis machines |
Fresenius Medical Care |
Gambro |
Nikkiso |
Hemodialysis concentrates |
Fresenius Medical Care |
Fuso |
Gambro |
Bloodlines |
Fresenius Medical Care |
Gambro |
Kawasumi |
Peritoneal dialysis products |
Baxter |
Fresenius Medical Care |
Pisa |
